Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03105336
Title A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (ZUMA-5)
Acronym ZUMA-5
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kite Pharma, Inc.
Age Groups: senior | adult
Covered Countries USA | FRA

No variant requirements are available.